Moderna
Trade Moderna 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRNA
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics.
MRNA Key Statistics
Stock Snapshot
With a market cap of 21.4B, Moderna(MRNA) trades at $53.83. The stock has a price-to-earnings ratio of -7.52.
On 2026-04-21, Moderna(MRNA) stock traded between a low of $51.68 and a high of $56.20. Shares are currently priced at $53.83, which is +4.2% above the low and -4.2% below the high.
Moderna(MRNA) shares are trading with a volume of 6.2M, against a daily average of 6.1M.
In the last year, Moderna(MRNA) shares hit a 52-week high of $59.55 and a 52-week low of $22.28.
In the last year, Moderna(MRNA) shares hit a 52-week high of $59.55 and a 52-week low of $22.28.
MRNA News
The company states: “Moderna (MRNA) announced that the first participants in the U.S. and UK have been dosed in a Phase 3 study of the Company’s investigational...
Key Points Moderna's innovative technology could help it establish itself as a leader in the vaccine market. Regeneron has an exciting lineup of candidates, i...
William Blair analyst Myles Minter has reiterated their neutral stance on MRNA stock, giving a Hold rating today. Claim 30% Off TipRanks Unlock hedge fund-level...
Analyst ratings
72%
of 25 ratingsMore MRNA News
Moderna stock is showing upward movement. What’s pushing MRNA stock higher? FDA Grants Fast Track Designation To Treatment The FDA granted Fast Track designat...
Kura Oncology (KURA) shares rallied 8.3% in the last trading session to close at $9.68. This move can be attributable to notable volume with a higher number of...
Moderna recently presented positive Phase 1/2 data for its investigational cancer antigen therapy mRNA-4359 in combination with pembrolizumab in advanced melano...
Moderna (MRNA) announced that the Company will present data from a Phase 1/2 study of mRNA-4359, an investigational cancer antigen therapy, at the American Asso...
Advertisement Recent performance snapshot and why Moderna is on watch With no single headline event driving attention today, Moderna (MRNA) is drawing interes...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.